# Nanomedical Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanomedical-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: San Diego, US
- Website: www.nanomedicaldiagnostics.com
- Total disclosed funding: $1.6M
- Latest round: Series A (Oct 13, 2015)
- Investors on record: 1

## About

Nanomedical Diagnostics focuses on the development and production of advanced molecular sensors, utilizing innovative technology for precise chemical and biological sensing applications across various industries.Founded in 2013 and headquartered in San Diego, US, Nanomedical Diagnostics specializes in advanced molecular sensors. The company raised USD 1.6 mn in Series A funding in October 2015, led by Serra Ventures. The founder, Kiana Aran, has a background in the field, although no previous ventures are noted. The total amount raised by the company is USD 1.6 mn.Nanomedical Diagnostics develops and mass produces advanced molecular sensors, notably the GFET-PV01, an electrolyte-gated field-effect transistor (FET). This product features a proprietary method for depositing graphene, enhancing its operational consistency. The GFET-PV01 offers three channels for both manual and automated functionalization, catering to diverse applications in healthcare, environmental monitoring, and food safety, while being compatible with existing data acquisition systems for various research and industrial uses.Nanomedical Diagnostics operates on a revenue model that emphasizes direct sales of the GFET-PV01, complemented by potential partnerships with research institutions. Transactions are primarily business-to-business (B2B), where clients integrate the sensors into their applications. Their pricing reflects the sophisticated technology and materials utilized, alongside support services. Their sales strategy may also involve collaborations with academic and industry partners, ensuring a stable revenue stream through both direct product sales and strategic alliances.Looking ahead, Nanomedical Diagnostics plans to launch new products designed to enhance their sensor capabilities, although specific release dates are not mentioned. The company aims to expand its presence into new markets, particularly in Europe and Asia, to meet increasing demands for precise sensing technologies. The recent funding of USD 1.6 mn will support these initiatives, enabling the company to invest in product development and market expansion strategies.

## Funding rounds

- Series A, Oct 13, 2015, $1.6M — Serra Ventures

## Investors

- Serra Ventures (https://capitalatlas.ai/funds/serra-ventures) — Series A